ARS Pharmaceuticals
SPRY
SPRY
165 hedge funds and large institutions have $752M invested in ARS Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 61 increasing their positions, 42 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
165
Holders Change
+15
Holders Change %
+10%
% of All Funds
2.2%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.01%
New
37
Increased
61
Reduced
42
Closed
18
Calls
$2.68M
Puts
$3.65M
Net Calls
-$966K
Net Calls Change
-$5.94M
Top Buyers
| 1 |
1
AllianceBernstein
Nashville,
Tennessee
|
$40.9M |
| 2 |
2
Alyeska Investment Group
Chicago,
Illinois
|
$13.2M |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$10.7M |
| 4 |
4
State Street
Boston,
Massachusetts
|
$29M |
| 5 |
5
Goldman Sachs
New York
|
$9.35M |
